Expert Opinion on Pharmacotherapy, Volume 21, Issue 15 (2020)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Pharmacotherapy, Volume 21, Issue 15 (2020)

See all volumes and issues
Vol 25, 2024 Vol 24, 2023 Vol 23, 2022 Vol 22, 2021 Volume 21, 2020 Vol 20, 2019 Vol 19, 2018 Vol 18, 2017 Vol 17, 2016 Vol 16, 2015 Vol 15, 2014 Vol 14, 2013 Vol 13, 2012 Vol 12, 2011 Vol 11, 2010 Vol 10, 2009 Vol 9, 2008 Vol 8, 2007 Vol 7, 2006 Vol 6, 2005 Vol 5, 2004 Vol 4, 2003 Vol 3, 2002 Vol 2, 2001 Vol 1, 1999-2000
Download citations Download PDFs Download issue

Editorial

Editorial
What are the treatment options for resistant Klebsiella pneumoniae carbapenemase (KPC)-producing bacteria?
Martina Spaziante, Alessandra Oliva, Giancarlo Ceccarelli & Mario Venditti
Pages: 1781-1787
Published online: 17 Jun 2020
First Page PreviewforWhat are the treatment options for resistant Klebsiella pneumoniae carbapenemase (KPC)-producing bacteria? | Full Text | References | PDF (261.8 KB) | EPUB
  • 4871 Views
  • 7 CrossRef citations
  • 0Altmetric
Free Access
Editorial
What value do JAK inhibitors have in treating rheumatoid arthritis?
Christophe Richez & Marie-Elise Truchetet
Pages: 1789-1792
Published online: 25 Jun 2020
First Page PreviewforWhat value do JAK inhibitors have in treating rheumatoid arthritis? | Full Text | References | PDF (165 KB) | EPUB
  • 1380 Views
  • 4 CrossRef citations
  • 0Altmetric
Free Access

Drug Evaluations

Article
An update on the efficacy and safety of iloperidone as a schizophrenia therapy
Ajay Nair, Amanie Salem, Anna-Lee Asamoah, Ravipreet Gosal & George T Grossberg
Pages: 1793-1798
Published online: 31 Jul 2020
AbstractforAn update on the efficacy and safety of iloperidone as a schizophrenia therapy | Full Text | References | PDF (333.3 KB) | EPUB
  • 217 Views
  • 1 CrossRef citations
  • 0Altmetric

Drug Evaluation

Article
An up-to-date evaluation of sotagliflozin for the treatment of type 1 diabetes
Georgios Chatzopoulos & Konstantinos Tziomalos
Pages: 1799-1803
Published online: 27 Oct 2020
AbstractforAn up-to-date evaluation of sotagliflozin for the treatment of type 1 diabetes | Full Text | References | PDF (310.3 KB) | EPUB
  • 208 Views
  • 4 CrossRef citations
  • 0Altmetric
Article
Evaluating imipenem + cilastatin + relebactam for the treatment of complicated urinary tract infections
S.G. Kuiper, E. Leegwater, E.B. Wilms & C. van Nieuwkoop
Pages: 1805-1811
Published online: 21 Aug 2020
AbstractforEvaluating imipenem + cilastatin + relebactam for the treatment of complicated urinary tract infections | Full Text | References | PDF (385.2 KB) | EPUB
  • 263 Views
  • 3 CrossRef citations
  • 0Altmetric

Perspective

Pharmacotherapeutic considerations in solid organ transplant patients with COVID-19
Simin Dashti-Khavidaki, Keyhan Mohammadi, Hossein Khalili & Azin Abdollahi
Pages: 1813-1819
Published online: 13 Jul 2020
AbstractforPharmacotherapeutic considerations in solid organ transplant patients with COVID-19 | Full Text | References | PDF (317.9 KB) | EPUB
  • 1935 Views
  • 6 CrossRef citations
  • 0Altmetric

Review

The trade-off dilemma in pharmacotherapy of COVID-19: systematic review, meta-analysis, and implications
Sohil Khan, Michael R Gionfriddo, Nicolas Cortes-Penfield, Girish Thunga & Muhammad Rashid
Pages: 1821-1849
Published online: 04 Aug 2020
AbstractforThe trade-off dilemma in pharmacotherapy of COVID-19: systematic review, meta-analysis, and implications | Full Text | References | PDF (10.2 MB) | EPUB
  • 1241 Views
  • 4 CrossRef citations
  • 0Altmetric
Targeted pharmacotherapy for ischemia reperfusion injury in acute myocardial infarction
Amit Rout, Udaya S Tantry, Marko Novakovic, Ajaypaul Sukhi & Paul A Gurbel
Pages: 1851-1865
Published online: 13 Jul 2020
AbstractforTargeted pharmacotherapy for ischemia reperfusion injury in acute myocardial infarction | Full Text | References | PDF (817.5 KB) | EPUB
  • 1041 Views
  • 24 CrossRef citations
  • 0Altmetric
Treatment strategies for patients with atrial fibrillation and anticoagulant-associated intracranial hemorrhage: an overview of the pharmacotherapy
José Miguel Rivera-Caravaca, María Asunción Esteve-Pastor, Anny Camelo-Castillo, Inmaculada Ramírez-Macías, Gregory Y. H. Lip, Vanessa Roldán & Francisco Marín
Pages: 1867-1881
Published online: 13 Jul 2020
AbstractforTreatment strategies for patients with atrial fibrillation and anticoagulant-associated intracranial hemorrhage: an overview of the pharmacotherapy | Full Text | References | PDF (2.3 MB) | EPUB
  • 419 Views
  • 3 CrossRef citations
  • 0Altmetric
Drug treatment strategies for secondary diabetes in patients with acromegaly
Sylvère Störmann & Jochen Schopohl
Pages: 1883-1895
Published online: 07 Jul 2020
AbstractforDrug treatment strategies for secondary diabetes in patients with acromegaly | Full Text | References | PDF (408 KB) | EPUB
  • 291 Views
  • 3 CrossRef citations
  • 0Altmetric
Clinical guidance on pharmacotherapy for the treatment of attention-deficit hyperactivity disorder (ADHD) for people with intellectual disability
Jonjo Miller, Bhathika Perera & Rohit Shankar
Pages: 1897-1913
Published online: 21 Jul 2020
AbstractforClinical guidance on pharmacotherapy for the treatment of attention-deficit hyperactivity disorder (ADHD) for people with intellectual disability | Full Text | References | PDF (460.2 KB) | EPUB
  • 731 Views
  • 9 CrossRef citations
  • 0Altmetric
Efficacy and safety of idelalisib for the treatment of indolent B-cell malignancies
Piotr Smolewski & Dominika Rydygier
Pages: 1915-1926
Published online: 20 Jul 2020
AbstractforEfficacy and safety of idelalisib for the treatment of indolent B-cell malignancies | Full Text | References | PDF (700.9 KB) | EPUB
  • 161 Views
  • 2 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Oral glucagon-like peptide-1 receptor agonists and combinations of entero-pancreatic hormones as treatments for adults with type 2 diabetes: where are we now?
Prathima Gogineni et al.
Review Article | Published online: 22 May 2024
Open Access
Juxtaglomerular apparatus-mediated homeostatic mechanisms: therapeutic implication for chronic kidney disease
Eiji Higashihara et al.
Review Article | Published online: 22 May 2024
Open Access
Recent advances in pharmacological management of attention-deficit/hyperactivity disorder: moving beyond stimulants
Ann Childress
Review Article | Published online: 21 May 2024
Revolutionizing hepatitis C treatment: next-gen direct-acting antivirals
Krystyna Dobrowolska et al.
Review Article | Published online: 20 May 2024
View all latest articles